For men, testosterone replacement therapy (TRT) can significantly improve arousal, motivation, and performance
The latest Novo Nordisk press release shows that oral semaglutide (9mg) led to a significant reduction in cardiovascular events in the SOUL trial, as presented at ACC 2025
Methods: Thirty-two patients with T2D were evaluated at baseline (T0) and after three (T3) and six (T6) months of therapy with oral semaglutide
In clinical trials for type 2 diabetes (SURPASS), nausea was reported by approximately 12-29% of patients receiving tirzepatide, depending on the dose, compared to 6-8% receiving placebo
10 GLP-1 clinics in Glendale list that they accept insurance
D-SNP affiliated with managed long-term services and supports (MLTSS)